Cytokinetics, Incorporated (NASDAQ:CYTK) Q2 2025 Earnings Call Transcript August 8, 2025
Operator: Thank you for standing by. My name is Prilla, and I will be your conference operator today. Welcome to the Cytokinetics Q2 2025 Earnings Conference Call. This call is being recorded. [Operator Instructions] I would now like to turn the call over to Diane Weiser, Cytokinetics’ Senior Vice President of Corporate Affairs. Please go ahead.
Diane Weiser: Good afternoon, and thanks for joining us on...
